- Home
- CMPX vs DGICA Comparison
CMPX vs DGICA Comparison
Compare CMPX & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMPX | DGICA |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | 35 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 955.1M | 741.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CMPX | DGICA |
|---|---|---|
| Price | $5.22 | $19.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | $13.44 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 1.8M | 105.8K |
| Earning Date | 11-05-2025 | 02-19-2026 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | N/A | ★ 219.91 |
| EPS | N/A | ★ 2.38 |
| Revenue | N/A | ★ $987,826,105.00 |
| Revenue This Year | N/A | $2.26 |
| Revenue Next Year | N/A | $3.46 |
| P/E Ratio | ★ N/A | $8.39 |
| Revenue Growth | N/A | ★ 0.89 |
| 52 Week Low | $1.33 | $14.17 |
| 52 Week High | $5.86 | $21.12 |
Technical Indicators
Market Signals| Indicator | CMPX | DGICA |
|---|---|---|
| Relative Strength Index (RSI) | 54.27 | 40.77 |
| Support Level | $4.83 | $19.89 |
| Resistance Level | $5.53 | $20.42 |
| Average True Range (ATR) | 0.26 | 0.35 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 62.77 | 0.00 |
Price Performance
Historical ComparisonAbout CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.